Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
Public ClinicalTrials.gov record NCT04959032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in adult patients with a primary diagnosis of schizophrenia according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5).
Study identification
- NCT ID
- NCT04959032
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2021
- Primary completion
- Jul 24, 2024
- Completion
- Aug 6, 2024
- Last update posted
- Nov 6, 2024
2021 – 2024
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Little Rock | Arkansas | 72211 | — |
| Clinical Site | Bellflower | California | 907006 | — |
| Clinical Site | Cerritos | California | 90703 | — |
| Clinical Site | Culver City | California | 90230 | — |
| Clinical Site | Garden Grove | California | 92845 | — |
| Clinical Site | Lemon Grove | California | 91945 | — |
| Clinical Site | Montclair | California | 91763 | — |
| Clinical Site | Orange | California | 92869 | — |
| Clinical Site | Hollywood | Florida | 33021 | — |
| Clinical Site | Miami Lakes | Florida | 33016 | — |
| Clinical Site | Oakland Park | Florida | 33334 | — |
| Clinical Site | Atlanta | Georgia | 30331 | — |
| Clinical Site | Chicago | Illinois | 60640 | — |
| Clinical Site | Boston | Massachusetts | 02114 | — |
| Clinical Site | St Louis | Missouri | 63141 | — |
| Clinical Site | Las Vegas | Nevada | 89102 | — |
| Clinical Site | Berlin | New Jersey | 08009 | — |
| Clinical Site | North Canton | Ohio | 44720 | — |
| Clinical Site | Austin | Texas | 78754 | — |
| Clinical Site | DeSoto | Texas | 75115 | — |
| Clinical Site | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04959032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2024 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04959032 live on ClinicalTrials.gov.